Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Dec;72(6):1971–1976. doi: 10.1172/JCI111161

Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years.

G H Boers, A G Smals, F J Trijbels, A I Leermakers, P W Kloppenborg
PMCID: PMC437037  PMID: 6643682

Abstract

Premenopausal women develop occlusive artery disease less frequently than postmenopausal women. In coronary heart disease, higher blood levels of homocysteine-cysteine mixed disulphide have been reported. Therefore, in healthy subjects, we studied the role of menopausal status in the transsulphuration of methionine in 10 premenopausal and 10 postmenopausal women. To exclude the role of aging, we compared these results with those in 10 younger and 10 older men of comparable age groups. An oral methionine load (0.1 g/kg of body weight) was administered after overnight fasting. Before and during 8 h, thereafter, serum levels of methionine, homocystine, and homocysteine-cysteine mixed disulphide were measured. In the fasting state, serum methionine levels were similar in the premenopausal women and both groups of men. Postmenopausal women had significantly lower fasting levels. Peak levels and clearances of methionine after loading did not differ between the groups. In the fasting state, homocystine was never detectable; yet, after methionine loading, slight homocystinemia was present in 12 out of 20 men, and was more pronounced in all postmenopausal women. However, homocystinemia did not occur in any of the premenopausal women after loading. Fasting serum homocysteine-cysteine mixed disulphide levels did not differ between both groups of men and postmenopausal women. In premenopausal women, both fasting and postloading disulphide levels were significantly lower than in any other group. We conclude that premenopausal women have a unique efficiency of methionine handling, and thereby are preserved against the accumulation of homocysteine after methionine loading. We speculate that this phenomenon might account for the lower incidence of vascular disease in women in the reproductive life cycle.

Full text

PDF
1971

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. D., Stave U. A study of plasma free amino acid levels. II. Normal values for children and adults. Metabolism. 1973 Apr;22(4):561–569. doi: 10.1016/0026-0495(73)90069-3. [DOI] [PubMed] [Google Scholar]
  2. Bengtsson C. Ischaemic heart disease in women. A study based on a randomized population sample of women and women with myocardial infarction in Göteborg, Sweden. Acta Med Scand Suppl. 1973;549:1–128. [PubMed] [Google Scholar]
  3. Boers G. H., Smals A. G., Drayer J. I., Trijbels F. J., Leermakers A. I., Kloppenborg P. W. Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients. Metabolism. 1983 Apr;32(4):390–397. doi: 10.1016/0026-0495(83)90049-5. [DOI] [PubMed] [Google Scholar]
  4. Centerwall B. S. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol. 1981 Jan;139(1):58–61. doi: 10.1016/0002-9378(81)90412-9. [DOI] [PubMed] [Google Scholar]
  5. Gordon T., Kannel W. B., Hjortland M. C., McNamara P. M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978 Aug;89(2):157–161. doi: 10.7326/0003-4819-89-2-157. [DOI] [PubMed] [Google Scholar]
  6. Gupta V. J., Wilcken D. E. The detection of cysteine-homocysteine mixed disulphide in plasma of normal fasting man. Eur J Clin Invest. 1978 Aug;8(4):205–207. doi: 10.1111/j.1365-2362.1978.tb00853.x. [DOI] [PubMed] [Google Scholar]
  7. Harker L. A., Ross R., Slichter S. J., Scott C. R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976 Sep;58(3):731–741. doi: 10.1172/JCI108520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harker L. A., Slichter S. J., Scott C. R., Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med. 1974 Sep 12;291(11):537–543. doi: 10.1056/NEJM197409122911101. [DOI] [PubMed] [Google Scholar]
  9. McCully K. S., Wilson R. B. Homocysteine theory of arteriosclerosis. Atherosclerosis. 1975 Sep-Oct;22(2):215–227. doi: 10.1016/0021-9150(75)90004-0. [DOI] [PubMed] [Google Scholar]
  10. Milsom J. P., Morgan M. Y., Sherlock S. Factors affecting plasma amino acid concentrations in control subjects. Metabolism. 1979 Apr;28(4):313–319. doi: 10.1016/0026-0495(79)90101-x. [DOI] [PubMed] [Google Scholar]
  11. Mudd S. H., Poole J. R. Labile methyl balances for normal humans on various dietary regimens. Metabolism. 1975 Jun;24(6):721–735. doi: 10.1016/0026-0495(75)90040-2. [DOI] [PubMed] [Google Scholar]
  12. OEPEN H., OEPEN I. GESCHLECHTSSPEZIFISCHE KONZENTRATIONSUNTERSCHIEDE DER SERUM-AMINOSAEUREN. Klin Wochenschr. 1965 Feb 15;43:211–214. doi: 10.1007/BF02350857. [DOI] [PubMed] [Google Scholar]
  13. OLIVER M. F., BOYD G. S. Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. Lancet. 1959 Oct 31;2(7105):690–694. doi: 10.1016/s0140-6736(59)92129-4. [DOI] [PubMed] [Google Scholar]
  14. ROBINSON R. W., HIGANO N., COHEN W. D. Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch Intern Med. 1959 Dec;104:908–913. doi: 10.1001/archinte.1959.00270120064010. [DOI] [PubMed] [Google Scholar]
  15. Rosenberg L., Hennekens C. H., Rosner B., Belanger C., Rothman K. J., Speizer F. E. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981 Jan;139(1):47–51. doi: 10.1016/0002-9378(81)90410-5. [DOI] [PubMed] [Google Scholar]
  16. Ryan K. R. Estrogens and atherosclerosis. Clin Obstet Gynecol. 1976 Dec;19(4):805–815. doi: 10.1097/00003081-197612000-00008. [DOI] [PubMed] [Google Scholar]
  17. Sardharwalla I. B., Fowler B., Robins A. J., Komrower G. M. Detection of heterozygotes for homocystinuria. Study of sulphur-containing amino acids in plasma and urine after L-methionine loading. Arch Dis Child. 1974 Jul;49(7):553–559. doi: 10.1136/adc.49.7.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wall R. T., Harlan J. M., Harker L. A., Striker G. E. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980 Apr 1;18(1-2):113–121. doi: 10.1016/0049-3848(80)90175-9. [DOI] [PubMed] [Google Scholar]
  19. Wilcken D. E., Gupta V. J., Betts A. K. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin Sci (Lond) 1981 Dec;61(6):743–749. doi: 10.1042/cs0610743. [DOI] [PubMed] [Google Scholar]
  20. Wilcken D. E., Gupta V. J. Cysteine-homocysteine mixed disulphide: differing plasma concentrations in normal men and women. Clin Sci (Lond) 1979 Aug;57(2):211–215. doi: 10.1042/cs0570211. [DOI] [PubMed] [Google Scholar]
  21. Wilcken D. E., Gupta V. J., Reddy S. G. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin Sci (Lond) 1980 May;58(5):427–430. doi: 10.1042/cs0580427. [DOI] [PubMed] [Google Scholar]
  22. Wilcken D. E., Gupta V. J. Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest. 1979 Aug;9(4):301–307. doi: 10.1111/j.1365-2362.1979.tb00888.x. [DOI] [PubMed] [Google Scholar]
  23. Wilcken D. E., Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976 Apr;57(4):1079–1082. doi: 10.1172/JCI108350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. de Groot P. G., Willems C., Boers G. H., Gonsalves M. D., van Aken W. G., van Mourik J. A. Endothelial cell dysfunction in homocystinuria. Eur J Clin Invest. 1983 Oct;13(5):405–410. doi: 10.1111/j.1365-2362.1983.tb00121.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES